Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
14,965,850
-
Number of holders
-
30
-
Total 13F shares, excl. options
-
3,682,268
-
Shares change
-
-597,746
-
Total reported value, excl. options
-
$12,334,180
-
Value change
-
-$2,453,600
-
Put/Call ratio
-
0%
-
Number of buys
-
14
-
Number of sells
-
-18
-
Price
-
$3.35
Significant Holders of CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) as of Q2 2025
44 filings reported holding CPIX - CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value as of Q2 2025.
CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) has 30 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3,682,268 shares
of 14,965,850 outstanding shares and own 24.6% of the company stock.
Largest 10 shareholders include MILLENNIUM MANAGEMENT LLC (775,976 shares), Ikarian Capital, LLC (595,932 shares), RENAISSANCE TECHNOLOGIES LLC (494,963 shares), VANGUARD GROUP INC (411,786 shares), DIMENSIONAL FUND ADVISORS LP (252,889 shares), J. Goldman & Co LP (220,707 shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (188,355 shares), BOOTHBAY FUND MANAGEMENT, LLC (180,229 shares), GEODE CAPITAL MANAGEMENT, LLC (100,237 shares), and CITADEL ADVISORS LLC (74,406 shares).
This table shows the top 30 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.